| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/16/2008 | EP1911445A2 Stable pharmaceutical formulation comprising an HMG-COA reductase inhibitor |
| 04/16/2008 | EP1911442A2 Preparation for the prevention and/or treatment of vascular disorders |
| 04/16/2008 | EP1911441A2 Controlled release color stable pharmaceutical dosage form of HMG-COA reductase inhibitors, free of alkalizing or buffering agents |
| 04/16/2008 | EP1911358A1 New composition for improving skin quality and a process for preparing the same |
| 04/16/2008 | EP1910844A2 Cross-beta structure binding compounds |
| 04/16/2008 | EP1910842A2 A method for detecting peptides comprising a cross-beta structure |
| 04/16/2008 | EP1910838A2 Cancer specific glycans and use thereof |
| 04/16/2008 | EP1910548A1 Method of delivering nucleic acid molecules into embryonic stem cells using baculoviral vectors |
| 04/16/2008 | EP1910539A2 Identification of jak/stat pathway modulating genes by genome wide rnai screening |
| 04/16/2008 | EP1910402A2 3-ester prodrugs of estradiol |
| 04/16/2008 | EP1910401A2 3-ester prodrugs of ethynylestradiol |
| 04/16/2008 | EP1910400A2 Improved crystalline form of the compound a-348441 |
| 04/16/2008 | EP1910398A1 17-alpha-substituted derivatives of estradiol with wound-healing activity |
| 04/16/2008 | EP1910395A2 Compositions and methods for modulation of smn2 splicing |
| 04/16/2008 | EP1910390A2 Glucopyranosyl-substituted ((hetero)cycloalyklethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter (sglt) inhibitors |
| 04/16/2008 | EP1910385A1 Benzothiazoles and thiazolopyridines as sirtuin modulators |
| 04/16/2008 | EP1910384A1 Imidazo [2,1-b]thiayole derivatives as sirtuin modulating compounds |
| 04/16/2008 | EP1910383A1 Benzodiazepine derivatives and uses thereof in medical field |
| 04/16/2008 | EP1910381A2 Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-on- compounds and the use thereof for producing drugs |
| 04/16/2008 | EP1910380A1 Oxazolopyridine derivatives as sirtuin modulators |
| 04/16/2008 | EP1910379A2 Caspase inhibitor prodrugs |
| 04/16/2008 | EP1910378A1 Hepatitis c inhibitor peptide analogs |
| 04/16/2008 | EP1910377A2 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 04/16/2008 | EP1910376A1 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 04/16/2008 | EP1910375A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 04/16/2008 | EP1910374A1 Azacyclic compounds as inhibitors of sensory neurone specific sodium channels |
| 04/16/2008 | EP1910370A1 A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor |
| 04/16/2008 | EP1910369A1 Fused heterocycles as lck inhibitors |
| 04/16/2008 | EP1910368A1 Pyrazolo[1.5-a]pyrimidin-7-yl amine derivatives as protein kinase inhibitors |
| 04/16/2008 | EP1910367A2 Pyrimidine or triazine fused bicyclic metalloprotease inhibitors |
| 04/16/2008 | EP1910366A2 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them |
| 04/16/2008 | EP1910365A2 Inhibitors of checkpoint kinases |
| 04/16/2008 | EP1910364A2 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/16/2008 | EP1910363A2 Hiv integrase inhibitors |
| 04/16/2008 | EP1910362A1 Imidazopyridine derivatives as sirtuin modulating agents |
| 04/16/2008 | EP1910361A2 Substituted tetrahydro-1h-pyrido[4,3,b]indoles as serotonin receptor agonists and antagonists |
| 04/16/2008 | EP1910360A2 Hiv reverse transcriptase inhibitors |
| 04/16/2008 | EP1910359A1 PYRIDO [2 , 3-D]PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS |
| 04/16/2008 | EP1910358A2 Heterocyclic janus kinase 3 inhibitors |
| 04/16/2008 | EP1910356A2 Hiv integrase inhibitors |
| 04/16/2008 | EP1910354A2 Novel method for producing tiotropium salts |
| 04/16/2008 | EP1910353A1 Tricyclic delta- opioid modulators |
| 04/16/2008 | EP1910352A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/16/2008 | EP1910350A1 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
| 04/16/2008 | EP1910349A1 2-arylbenzothiazoles and uses thereof |
| 04/16/2008 | EP1910348A2 Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
| 04/16/2008 | EP1910347A2 Macrocylic inhibitors of hepatitis c virus |
| 04/16/2008 | EP1910346A2 Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonist |
| 04/16/2008 | EP1910345A1 Substituted amides, their preparation and their use as pharmaceuticals |
| 04/16/2008 | EP1910344A2 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/16/2008 | EP1910342A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 04/16/2008 | EP1910341A2 Inhibitors of serine proteases |
| 04/16/2008 | EP1910340A1 Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| 04/16/2008 | EP1910339A2 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/16/2008 | EP1910338A2 Heterotetracyclic compounds as tpo mimetics |
| 04/16/2008 | EP1910336A1 Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 04/16/2008 | EP1910335A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof |
| 04/16/2008 | EP1910333A1 Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
| 04/16/2008 | EP1910332A2 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 04/16/2008 | EP1910330A1 Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
| 04/16/2008 | EP1910329A1 4-chromenonyl-1,4-dihydropyridines and their use |
| 04/16/2008 | EP1910326A1 Antitumoral compounds |
| 04/16/2008 | EP1910325A2 New pharmaceutical compounds |
| 04/16/2008 | EP1910322A2 Novel benzo [d][1,3]-dioxol derivatives |
| 04/16/2008 | EP1910321A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease |
| 04/16/2008 | EP1910317A1 1-amino linked compounds |
| 04/16/2008 | EP1910316A1 Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists |
| 04/16/2008 | EP1910315A2 Benzodiazepine derivatives, their preparation and the therapeutic use thereof |
| 04/16/2008 | EP1910314A1 Benzimidazole derivatives for treatment of inflammatory diseases |
| 04/16/2008 | EP1910313A1 6-thioamide substituted benzimidazoles |
| 04/16/2008 | EP1910312A1 Quadratic acid ii derivatives |
| 04/16/2008 | EP1910311A2 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 04/16/2008 | EP1910310A1 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 04/16/2008 | EP1910309A2 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR ß-SECRETASE MODULATION |
| 04/16/2008 | EP1910308A1 Imidazole based lxr modulators |
| 04/16/2008 | EP1910307A1 Pyrazole based lxr modulators |
| 04/16/2008 | EP1910302A1 Carbonyl substituted pyrazoline compounds, their preparation and use as cb1 receptor modulators |
| 04/16/2008 | EP1910301A2 Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/16/2008 | EP1910300A2 Prodrugs of pyrazoline compounds, their preparation and use as medicaments |
| 04/16/2008 | EP1910299A1 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 04/16/2008 | EP1910298A2 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants |
| 04/16/2008 | EP1910297A1 Isoquinoline compounds |
| 04/16/2008 | EP1910296A2 4-aryloxy quinoline derivatives as 5-ht6 modulators |
| 04/16/2008 | EP1910295A1 Substituted pyridocarboxamides as inhibitors of plasminogen activator inhibitor 1 (pai-1) |
| 04/16/2008 | EP1910294A1 A process for the preparation of substituted phenyl ether compounds and rosiglitazone |
| 04/16/2008 | EP1910293A1 Isotopically substituted proton pump inhibitors |
| 04/16/2008 | EP1910292A1 Piperidine derivative as tachykinin receptor antagonist |
| 04/16/2008 | EP1910290A2 Gpcr agonists |
| 04/16/2008 | EP1910288A1 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof |
| 04/16/2008 | EP1910287A1 Process for the preparation of crystalline perindopril |
| 04/16/2008 | EP1910285A1 Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof |
| 04/16/2008 | EP1910284A1 Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof |
| 04/16/2008 | EP1910282A1 Pleuromutilin derivatives useful as antibacterials |
| 04/16/2008 | EP1910279A2 Non-nucleoside anti-hepacivirus agents and uses thereof |
| 04/16/2008 | EP1910278A1 Amidonitrile compounds |
| 04/16/2008 | EP1910275A2 Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field |
| 04/16/2008 | EP1910274A1 Phenyl compounds |
| 04/16/2008 | EP1910273A2 10-substituted tetracyclines and methods of use thereof |
| 04/16/2008 | EP1910270A2 Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field |
| 04/16/2008 | EP1909912A2 Use of collismycin and derivatives thereof as oxidative stress inhibitors |